Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Dec 25;29(1):127.
doi: 10.3390/molecules29010127.

Research Progress Regarding the Effect and Mechanism of Dietary Polyphenols in Liver Fibrosis

Jiayin Chang  1 , Congying Huang  1 , Siqi Li  1 , Xiaolei Jiang  1 , Hong Chang  1 , Minhui Li  1   2   3
Affiliations
Review

Research Progress Regarding the Effect and Mechanism of Dietary Polyphenols in Liver Fibrosis

Jiayin Chang et al. Molecules. .

Abstract

The development of liver fibrosis is a result of chronic liver injuries may progress to liver cirrhosis and liver cancer. In recent years, liver fibrosis has become a major global problem, and the incidence rate and mortality are increasing year by year. However, there are currently no approved treatments. Research on anti-liver-fibrosis drugs is a top priority. Dietary polyphenols, such as plant secondary metabolites, have remarkable abilities to reduce lipid metabolism, insulin resistance and inflammation, and are attracting more and more attention as potential drugs for the treatment of liver diseases. Gradually, dietary polyphenols are becoming the focus for providing an improvement in the treatment of liver fibrosis. The impact of dietary polyphenols on the composition of intestinal microbiota and the subsequent production of intestinal microbial metabolites has been observed to indirectly modulate signaling pathways in the liver, thereby exerting regulatory effects on liver disease. In conclusion, there is evidence that dietary polyphenols can be therapeutically useful in preventing and treating liver fibrosis, and we highlight new perspectives and key questions for future drug development.

Keywords: HSC; dietary polyphenols; intestinal microbes; liver fibrosis; signaling pathways.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Structure of common phenolic compounds.
Figure 1
Figure 1
Structure of common phenolic compounds.
Figure 2
Figure 2
The molecular pathways of liver fibrosis pathogenesis.
Figure 3
Figure 3
Dietary polyphenols act on liver fibrosis by regulating intestinal microbiota and metabolites.
See this image and copyright information in PMC

References

    1. Cheemerla S., Balakrishnan M. Global Epidemiology of Chronic Liver Disease. Clin. Liver Dis. 2021;17:365–370. doi: 10.1002/cld.1061. - DOI - PMC - PubMed
    1. Friedman S.L., Pinzani M. Hepatic fibrosis 2022: Unmet needs and a blueprint for the future. Hepatology. 2022;75:473–488. doi: 10.1002/hep.32285. - DOI - PMC - PubMed
    1. Shan L., Wang F., Zhai D., Meng X., Liu J., Lv X. New Drugs for Hepatic Fibrosis. Front. Pharmacol. 2022;13:874408. doi: 10.3389/fphar.2022.874408. - DOI - PMC - PubMed
    1. Tan Z., Sun H., Xue T., Gan C., Liu H., Xie Y., Yao Y., Ye T. Liver Fibrosis: Therapeutic Targets and Advances in Drug Therapy. Front. Cell Dev. Biol. 2021;9:730176. doi: 10.3389/fcell.2021.730176. - DOI - PMC - PubMed
    1. Altamirano-Barrera A., Barranco-Fragoso B., Méndez-Sánchez N. Management Strategies for Liver Fibrosis. Ann. Hepatol. 2017;16:48–56. doi: 10.5604/16652681.1226814. - DOI - PubMed